XML 54 R38.htm IDEA: XBRL DOCUMENT v3.25.3
Equity Compensation (Tables)
 6 Months Ended
Oct. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Warrant Activity

Strategic Advisor warrants and Asset Manager warrants are accounted for as equity classified share-based compensation award in accordance with ASC 718. Following is a summary of the activities of warrants for the six months ended October 31, 2025:

 

   Number of Warrants   Weighted Average Exercise Price   Aggregate Intrinsic Value 
Outstanding as of July 30, 2025   -   $-    - 
Granted   6,930,697    1.46      
Exercised   2,376,236    -      
Forfeited   -           
Expired   -           
Outstanding as of October 30, 2025   4,554,461   $2.22   $26,447,530 
Exercisable as of October 30, 2025   4,554,461   $2.22   $26,447,530 
Schedule of Key Assumption Inputs

The table below summarizes the key assumption inputs used for the valuation for the six months ended October 31, 2025:

 Schedule of Key Assumption Inputs

  

Asset Manager

Warrants

 
Stock Price  $17.7 
Exercise Price  $10.23 
Expected Term (in years)   5.00 
Risk-free interest rate   3.77%
Expected volatility   110%
Expected dividend yield   -
Schedule of Non Qualified Stock Option

A summary of the non-qualified stock options granted to directors under the 2017 and 2021 Equity Plans, during the three months ended October 31, 2025, are presented in the tables below:

 

   Number of Options   Weighted Average Exercise Price   Weighted
Average Remaining Contractual Term		   Aggregate Intrinsic Value 
                 
Outstanding, June 7, 2025   4,760   $113.34    3.5    - 
Granted   -   $-    -    - 
Exercised   -   $-    -    - 
Forfeited   -   $-    -    - 
Expired   (1,111)  $52.20    -    - 
Outstanding, October 31, 2025   3,649   $131.95    3.5    - 
Exercisable, October 31, 2025   3,649   $131.95    4.2    - 
Schedule of Restricted Units Activity

   Number of Units   Weighted Average Grant-Date Fair Value   Aggregate Intrinsic Value 
             
Outstanding, June 7, 2025   1,529   $8.18   $11,345 
Granted   530,139   $8.88    3,934,967 
Vested and settled with share issuance   (4,189)  $8.95    (31,082)
Forfeited/cancelled   -   $-    - 
Outstanding, October 31, 2025   527,659   $8.89   $3,915,230 
2017 Equity Plan and 2021 Equity Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the period from June 7, 2025 through October 31, 2025, are presented in the tables below, including information on nonvested options:

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term   Aggregate Intrinsic Value 
                     
Outstanding as of June 7, 2025   18,296   $83.19    5.20    - 
Granted   2,700   $7.74    9.62    - 
Exercised   -   $-    -    - 
Forfeited   (450)  $7.74    -    - 
Expired   (150)  $8.99    -    - 
Outstanding as of October 31, 2025   20,396   $74.68    5.34    - 
Exercisable as of October 31, 2025   18,146   $82.98    4.81    -